SCHEMBL17090573

SCHEMBL17090573

Cc1ccc2nc(NC(=O)OC(C)(C)C)sc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 9/20 0.69
DYRK1A Q13627 1/20 0.67
MAP3K5 Q99683 1/20 0.62
NPC1 O15118 5/20 0.62
RAB9A P51151 5/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
TP53 P04637 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.61
PTPN1 P18031 1/20 0.60
ALDH1A1 P00352 2/20 0.59
ACP1 P24666 1/20 0.58
MAPT P10636 1/20 0.56
OPRK1 P41145 1/20 0.56
HTT P42858 1/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
HPGD P15428 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29506738 1.00 LCK (0.69) LCKDYRK1AMAP3K5NPC1RAB9A
SCHEMBL2666847 0.87 DYRK1A (0.67) LCKDYRK1ARAB9A
SCHEMBL14614351 0.87 DYRK1A (0.60) LCKDYRK1AMAP3K5NPC1RAB9A
SCHEMBL14113317 0.86 DYRK1A (0.74) DYRK1AMAP3K5NPC1RAB9ASMN1; SMN2
SCHEMBL29809436 0.86 RAB9A (0.76) LCKDYRK1ANPC1RAB9A
SCHEMBL30263005 0.86 LCK (0.61) LCKNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL3943412 0.86 LCK (0.61) LCKNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL10118217 0.86 RAB9A (0.76) LCKDYRK1ANPC1RAB9A
SCHEMBL3122011 0.85 LCK (0.60) LCKDYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL28706165 0.85 LCK (0.60) LCKDYRK1ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114230522-A Imidazole-2-carboxylic acid metal beta-lactamase inhibitor and preparation method and application thereof 四川大学 2022-03-25 CN disclosed
US-9138427-B2 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents NIVALIS THERAPEUTICS, INC. (US) 2015-09-22 US disclosed